Martin Newcomb
Hematology & Oncology · Laurel, MSNPI 1104821123
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $842 and has fallen 96.0% since, to $34 in 2024. That places this record below the midpoint for hematology & oncology clinicians in MS, where the typical reported total is $9,632.
Across 90 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$166
- Merck$136
- Johnson & Johnson$85
- Lilly USA, LLC$69
- Sanofi$57
- GSK$46
- plus $802 from 32 others
What the payments were for
- Food & beverage$1,34999%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $166 |
| Merck | 9 | $136 |
| Johnson & Johnson(2 entities) | 6 | $85 |
| Lilly USA, LLC | 5 | $69 |
| Sanofi | 4 | $57 |
| GSK | 3 | $46 |
| AstraZeneca | 3 | $44 |
| Coherus Oncology, Inc. | 3 | $44 |
| Acceleron Pharma, Inc. | 3 | $43 |
| Morphosys, US Inc. | 3 | $42 |
| Astellas Pharma US Inc | 3 | $41 |
| Sanofi-aventis U.S. LLC | 3 | $38 |
| Incyte Corporation | 2 | $37 |
| Dova Pharmaceuticals | 2 | $37 |
| AbbVie | 1 | $34 |
| Pharmacosmos Therapeutics Inc. | 2 | $33 |
| Exelixis Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Global Blood Therapeutics, Inc. | 2 | $28 |
| Rigel Pharmaceuticals, Inc. | 2 | $27 |
| Bayer | 2 | $27 |
| Novartis | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Tersera Therapeutics LLC | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Innate Pharma, Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $13 |
| Beigene USA, Inc. | 1 | $13 |
| Puma Biotechnology, Inc. | 1 | $13 |
| Blueprint Medicines Corporation | 1 | $13 |
| Seagen Inc. | 1 | $12 |
| Bristol Myers Squibb | 1 | $12 |
| Deciphera Pharmaceuticals Inc. | 1 | $12 |
| Gilead | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
How this compares
$1,361 in reported general payments places this provider in the 5th percentile of 57 hematology & oncology providers in Mississippi.
Other hematology & oncology in Laurel
- Solly ChedidPascagoula$1.7M
- Carter MilnerJackson$248K
- Guangzhi QuJackson$59K
- Jennifer EubanksMeridian$44K
- Daniel PattersonPascagoula$36K
- John HeneganJackson$35K
- Pamela TuliGulfport$27K
- Sonia BennSouthaven$26K
- Ronald DelrieMcComb$24K
- Matthew CassellMeridian$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.